It appears as though another Baxter International product may be implicated in patient’s injuries. United States health officials are investigating whether or not the deaths of two patients in a Delaware hospital are linked to a brand of heparin blood thinner sold by Baxter in intravenous bags.
The Beebe Medical Center in Lewes, Delaware, has suspended the use of Baxter’s heparin, following complications, including bleeding of the brain, with five patients.
This current scare comes on the heels of a larger recall of Baxter heparin that occurred last year.
